Sign in
4

Changes in Ownership

IRulya Therapeutics Inc. Filed Acc 0001209191-23-045234

Chief Business Officer bought 71,762 shares at $1.22 ($87,550)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Hannah Brendan Chief Business Officer 2023-08-08 Purchase +71,762 $1.22 $87,550 201,555 D
Open-market purchases · 71,762 sh · avg $1.22 · $87,550
Loading xslF345X05/doc4.xml…